Trending

pharma innovation

The sky’s the limit for LEO Pharma’s R&D hub

The sky’s the limit for LEO Pharma’s R&D hub

As part of pharmaphorum’s eye-on-innovation series of interviews, Richard Staines speaks to Michael Sierra, Vice President of LEO

X

The sky’s the limit for LEO Pharma’s R&D hub

https://pharmaphorum.com/views-analysis-digital/skys-limit-leo-pharma-rd-hub/

Servier expands global footprint post Shire deal

Servier expands global footprint post Shire deal

Following its acquisition of Shire’s oncology business in April, Servier is taking steps to expand its presence in the US and China.

X

Servier expands global footprint post Shire deal

https://pharmaphorum.com/news/servier-expands-footprint-shire/

Can ‘design thinking’ revolutionise pharma’s culture?

Can ‘design thinking’ revolutionise pharma’s culture?

As part of pharmaphorum’s ‘eye-on-innovation’ series, Paul Tunnah speaks to UCB’s head of innovation, Gregory Miller, about how

X

Can ‘design thinking’ revolutionise pharma’s culture?

https://pharmaphorum.com/views-and-analysis/can-design-thinking-revolutionise-pharmas-culture/

Merck KGaA celebrates 350 years of innovation

Merck KGaA celebrates 350 years of innovation

As part of pharmaphorum’s eye-on-innovation interview series, Paul Tunnah speaks to Merck Biopharma’s vice president of innovation Ulrich

X

Merck KGaA celebrates 350 years of innovation

https://pharmaphorum.com/views-analysis-digital/merck-kgaa-celebrates-350-years-innovation/

Innovation, endpoints and education – what’s in store for pharma in future-healthcare?

Innovation, endpoints and education – what’s in store for pharma in future-healthcare?

As part of pharmaphorum’s ‘eye-on-innovation’ interview series, Paul Tunnah speaks to Bayer’s Chief Marketing Officer Pharmaceuticals, Sebastian Guth,

X

Innovation, endpoints and education – what’s in store for pharma in future-healthcare?

https://pharmaphorum.com/views-and-analysis/innovation-endpoints-education-whats-store-pharma-future-healthcare/

Three trends driving the next frontier in healthcare

Three trends driving the next frontier in healthcare

A review of some of the cutting-edge start-ups and key themes that were evident at the Frontiers Health event.

X

Three trends driving the next frontier in healthcare

https://pharmaphorum.com/views-and-analysis/three-trends-driving-next-frontier-healthcare/

Escalier raises $19m to fund novel psoriasis pill

Escalier raises $19m to fund novel psoriasis pill

Escalier Biosciences, a privately-held biopharma company based in The Netherlands, has raised $19 million to help advance its

X

Escalier raises $19m to fund novel psoriasis pill

https://pharmaphorum.com/news/escalier-raises-19m-fund-novel-psoriasis-pill/

A new fast track for NHS access – good news for niche innovators

A new fast track for NHS access – good news for niche innovators

The UK is about to launch The Accelerated Access Collaborative: a new initiative aimed at speeding potential breakthroughs

X

A new fast track for NHS access – good news for niche innovators

https://pharmaphorum.com/views-and-analysis/accelerated-access-collaborativea-fast-track-for-nhs-access-good-news-for-niche-innovators/

Healthcare in 2030: what role for pharma?

Healthcare in 2030: what role for pharma?

Prevention and self-management increasingly important in healthcare systems of the future.

X

Healthcare in 2030: what role for pharma?

https://pharmaphorum.com/views-and-analysis/healthcare-2030-pharma/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com